Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

CMS wants patients to know the cost of Part D drugs in real time in proposed rule

CMS has issued a proposed rule and Advance Notice affecting Medicare Advantages and Medicare Part D prescription drug plans.

Thumbnail

Top 10 biggest health insurance companies

The top 10 largest insurers collectively wrote 51.8% of all healthcare premiums in the U.S. market in 2018.

Thumbnail

Trump asks for bill to lower drug prices in State of the Union address

President Donald Trump gave his annual State of the Union address on Feb. 4, calling on Congress to take on sky-high prescription drug prices.

In Iowa caucuses, healthcare issue takes center stage

Healthcare was top of mind among Iowa caucus-goers as the start of the 2020 election kicked off in the state on Feb. 3. About 60% of Democrats at the Iowa caucuses said they support eliminating private health insurance and moving to a single-payer healthcare system.

Thumbnail

Coronavirus is deadly and expensive

The novel coronavirus, which originated in Wuhan, China, has become the world’s most expensive epidemic, according to data from Learnbonds.com. In fact, the virus, which has been compared to SARS and MERS, is expected to cost China about 2% of its GDP during the first quarter of 2020, or $62 billion.

 

Thumbnail

Former Aetna CEO cites ‘tension’ in CVS board changes

The former CEO of health insurer Aetna, which was acquired by CVS Health for $69 billion at the end of 2018, says he is being pushed off the board of the combined company.

 

Thumbnail

Trump admin’s Medicaid block grants met with industry backlash

Medicaid block grants, which have been framed as an “opportunity” for states to better control their Medicaid spending and gain flexibility, have been harshly criticized by healthcare groups.

Thumbnail

Will AI be a part of Trump’s State of the Union address?

President Trump is scheduled to deliver his State of the Union address on Tuesday, Feb. 4, at a time when most Americans have been focused on impeachment, the 2020 election and the coronavirus outbreak.

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Mark Isenberg, executive vice president of Zotec Partners, discusses key developments that will reshape the specialty this year. 

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.